|
|
|
|
|
|
|
|
At ImmunoSolv we have developed novel Dead-Cert® reagents and services for detection and depletion of non-viable cells to improve cell populations in the laboratory or biomanufacturing facility. |
|
|
| |
|
| |
 |
| |
|
|
|
|
Dead-Cert® products for specific applications
available
from May 2010
Distributors in North America and Japan announced
Immunosolv products will be distributed in Canada and the USA by Cedarlane Laboratories and in Japan by Funakoshi. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
We are also applying our Dead-Cert® technology to:
- Improve production and delivery of therapeutic cells and proteins.
- Develop novel anti-cancer therapeutics targeting the host immune response to dying cells.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|